Published in J Immunol on December 15, 1998
The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol (2009) 3.72
Control of immunity by the TNFR-related molecule OX40 (CD134). Annu Rev Immunol (2010) 2.67
Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus. Nat Genet (2007) 2.38
OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation. J Exp Med (2003) 2.26
In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation. J Clin Invest (2007) 2.18
Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers. J Exp Med (1999) 2.15
Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. Proc Natl Acad Sci U S A (2006) 1.87
Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40. J Exp Med (2001) 1.74
Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand. J Exp Med (2000) 1.73
The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol Rev (2009) 1.70
OX40 is a potent immune-stimulating target in late-stage cancer patients. Cancer Res (2013) 1.57
Signals from OX40 regulate nuclear factor of activated T cells c1 and T cell helper 2 lineage commitment. Proc Natl Acad Sci U S A (2006) 1.54
The role of OX40-mediated co-stimulation in T-cell activation and survival. Crit Rev Immunol (2009) 1.39
A critical role for OX40 in T cell-mediated immunopathology during lung viral infection. J Exp Med (2003) 1.35
Immunotherapy in the treatment of non-small cell lung cancer. Lung Cancer (2014) 1.35
Cutting Edge: OX40 agonists can drive regulatory T cell expansion if the cytokine milieu is right. J Immunol (2009) 1.32
An extended vision for dynamic high-resolution intravital immune imaging. Semin Immunol (2005) 1.32
Signaling through OX40 enhances antitumor immunity. Semin Oncol (2010) 1.27
Antagonism of airway tolerance by endotoxin/lipopolysaccharide through promoting OX40L and suppressing antigen-specific Foxp3+ T regulatory cells. J Immunol (2008) 1.27
Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD). Philos Trans R Soc Lond B Biol Sci (2005) 1.26
Activation of NF-kappaB1 by OX40 contributes to antigen-driven T cell expansion and survival. J Immunol (2008) 1.25
Role of OX40 signals in coordinating CD4 T cell selection, migration, and cytokine differentiation in T helper (Th)1 and Th2 cells. J Exp Med (2000) 1.22
Clinical relevance of host immunity in breast cancer: from TILs to the clinic. Nat Rev Clin Oncol (2015) 1.22
OX40 ligand expressed by DCs costimulates NKT and CD4+ Th cell antitumor immunity in mice. J Clin Invest (2007) 1.21
GM-CSF-induced, bone-marrow-derived dendritic cells can expand natural Tregs and induce adaptive Tregs by different mechanisms. J Leukoc Biol (2010) 1.19
Thymic OX40 expression discriminates cells undergoing strong responses to selection ligands. J Immunol (2009) 1.18
The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy. Curr Opin Immunol (2013) 1.16
OX40 costimulatory signals potentiate the memory commitment of effector CD8+ T cells. J Immunol (2008) 1.12
CD28-independent induction of experimental autoimmune encephalomyelitis. J Clin Invest (2001) 1.10
Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice. J Immunother (2010) 1.10
Functional cooperation between T helper cell determinants. Proc Natl Acad Sci U S A (2000) 1.09
Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells. J Immunol (2012) 1.08
OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling. J Immunol (2011) 1.08
Expansion of activated human naïve T-cells precedes effector function. Clin Exp Immunol (2002) 1.07
New insights on OX40 in the control of T cell immunity and immune tolerance in vivo. J Immunol (2011) 1.06
OX40 facilitates control of a persistent virus infection. PLoS Pathog (2012) 1.05
Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy. ISRN Oncol (2013) 1.04
TNF receptor-associated factor 5 is required for optimal T cell expansion and survival in response to infection. J Immunol (2008) 1.03
Development and characterization of recombinant human Fc:OX40L fusion protein linked via a coiled-coil trimerization domain. Mol Immunol (2007) 1.03
Distinct functions of autoreactive memory and effector CD4+ T cells in experimental autoimmune encephalomyelitis. Am J Pathol (2008) 1.03
Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity. Cancer Immunol Res (2013) 1.03
Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease. PLoS Genet (2014) 1.01
OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade. J Immunol (2009) 1.01
OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal. Front Oncol (2015) 1.01
Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cells. Proc Natl Acad Sci U S A (2011) 1.00
Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy for the treatment of prostate cancer. Urol Oncol (2006) 0.97
Airway wall expression of OX40/OX40L and interleukin-4 in asthma. Chest (2010) 0.96
Costimulation blockade: current perspectives and implications for therapy. Transplantation (2013) 0.95
The survival of memory CD4+ T cells within the gut lamina propria requires OX40 and CD30 signals. J Immunol (2009) 0.95
Costimulation signals for memory CD8+ T cells during viral infections. Crit Rev Immunol (2009) 0.94
The contribution of direct TLR signaling to T cell responses. Immunol Res (2009) 0.94
CD28 expression is required after T cell priming for helper T cell responses and protective immunity to infection. Elife (2014) 0.94
CD134 as target for specific drug delivery to auto-aggressive CD4+ T cells in adjuvant arthritis. Arthritis Res Ther (2005) 0.92
Activated T cells express the OX40 ligand: requirements for induction and costimulatory function. Immunology (2006) 0.92
Nasal cardiac myosin peptide treatment and OX40 blockade protect mice from acute and chronic virally-induced myocarditis. J Autoimmun (2011) 0.92
MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment. Glycoconj J (2003) 0.91
4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine. Immunology (2004) 0.91
Costimulatory pathways in transplantation. Semin Immunol (2011) 0.90
The small molecule TGF-β signaling inhibitor SM16 synergizes with agonistic OX40 antibody to suppress established mammary tumors and reduce spontaneous metastasis. Cancer Immunol Immunother (2011) 0.90
Immunity, cancer and aging: lessons from mouse models. Aging Dis (2011) 0.89
Targeting the CD134-CD134L interaction using anti-CD134 and/or rhCD134 fusion protein as a possible strategy to prevent lupus nephritis. Rheumatol Int (2008) 0.89
Dual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expression. PLoS One (2012) 0.88
The costimulatory molecules CD80, CD86 and OX40L are up-regulated in Aspergillus fumigatus sensitized mice. Clin Exp Immunol (2005) 0.86
Costimulation of naive human CD4 T cells through intercellular adhesion molecule-1 promotes differentiation to a memory phenotype that is not strictly the result of multiple rounds of cell division. Immunology (2006) 0.86
Cycling memory CD4+ T cells in HIV disease have a diverse T cell receptor repertoire and a phenotype consistent with bystander activation. J Virol (2014) 0.86
Th9 cells in the pathogenesis of EAE and multiple sclerosis. Semin Immunopathol (2016) 0.85
OX40 engagement stabilizes Mxd4 and Mnt protein levels in antigen-stimulated T cells leading to an increase in cell survival. Eur J Immunol (2011) 0.85
T lymphocyte dependence of the antibody response to 'T lymphocyte independent type 2' antigens. Immunology (2004) 0.84
Exogenous OX40 stimulation during lymphocytic choriomeningitis virus infection impairs follicular Th cell differentiation and diverts CD4 T cells into the effector lineage by upregulating Blimp-1. J Immunol (2013) 0.84
CD40/CD40L expression correlates with the survival of patients with glioblastomas and an augmentation in CD40 signaling enhances the efficacy of vaccinations against glioma models. Neuro Oncol (2015) 0.84
OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity. Int J Cancer (2009) 0.83
Targeting macrophages in the tumour environment to enhance the efficacy of αOX40 therapy. Immunology (2012) 0.83
Betting on improved cancer immunotherapy by doubling down on CD134 and CD137 co-stimulation. Oncoimmunology (2013) 0.82
Regulation of the PKCθ-NF-κB Axis in T Lymphocytes by the Tumor Necrosis Factor Receptor Family Member OX40. Front Immunol (2012) 0.82
Apoptosis-regulated low-avidity cancer-specific CD8(+) T cells can be rescued to eliminate HER2/neu-expressing tumors by costimulatory agonists in tolerized mice. Cancer Immunol Res (2014) 0.81
The role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosis. J Biomed Biotechnol (2011) 0.81
Targeting CD8+ T-cell tolerance for cancer immunotherapy. Immunotherapy (2014) 0.81
Essential role of OX40L on B cells in persistent alloantibody production following repeated alloimmunizations. J Clin Immunol (2004) 0.81
A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen. J Immunol (2013) 0.81
Antigen inhibition of collagen-induced arthritis is associated with up-regulation of IL-4 mRNA and induction of Ox40 on T cells in draining lymph nodes. Clin Exp Immunol (2003) 0.81
Decreased 4-1BB expression on HIV-specific CD4+ T cells is associated with sustained viral replication and reduced IL-2 production. Clin Immunol (2009) 0.81
The influence of CD4 T-cell subsets on control of CD4 T-cell-mediated graft-versus-host disease. Immunology (2008) 0.80
OX40 controls effector CD4+ T-cell expansion, not follicular T helper cell generation in acute Listeria infection. Eur J Immunol (2014) 0.80
Indispensable roles of OX40L-derived signal and epistatic genetic effect in immune-mediated pathogenesis of spontaneous pulmonary hypertension. BMC Immunol (2011) 0.80
OX40 ligand fusion protein delivered simultaneously with the BCG vaccine provides superior protection against murine Mycobacterium tuberculosis infection. J Infect Dis (2012) 0.80
Enforced covalent trimerisation of soluble feline CD134 (OX40)-ligand generates a functional antagonist of feline immunodeficiency virus. Mol Immunol (2009) 0.79
Cancer stem cells and immunoresistance: clinical implications and solutions. Transl Lung Cancer Res (2015) 0.79
Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response. Immunology (2003) 0.79
T-cell activation and transplantation tolerance. Transplant Rev (Orlando) (2011) 0.78
Combined treatment with dabrafenib and trametinib with immune-stimulating antibodies for BRAF mutant melanoma. Oncoimmunology (2015) 0.78
Ox40L-Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major. Exp Parasitol (2014) 0.77
Blockade of OX40-ligand after initial triggering of the T helper 2 response inhibits mercuric chloride-induced autoimmunity. Immunology (2006) 0.77
Activation and Costimulation of Intestinal T Cells: Independent and Collaborative Involvement of CD43, OX40, and Ly-6C. Curr Immunol Rev (2005) 0.77
Inhibitors of B7-CD28 costimulation in urologic malignancies. Immunotherapy (2009) 0.77
Low-Intensity Focused Ultrasound Induces Reversal of Tumor-Induced T Cell Tolerance and Prevents Immune Escape. J Immunol (2016) 0.76
Combined mTOR inhibition and OX40 agonism enhances CD8(+) T cell memory and protective immunity produced by recombinant adenovirus vaccines. Mol Ther (2011) 0.76
Rhinovirus infection interferes with induction of tolerance to aeroantigens through OX40 ligand, thymic stromal lymphopoietin, and IL-33. J Allergy Clin Immunol (2015) 0.76
Basophil-associated OX40 ligand participates in the initiation of Th2 responses during airway inflammation. J Biol Chem (2015) 0.75
Association of TNFSF4 Polymorphisms with Vogt-Koyanagi-Harada and Behcet's Disease in Han Chinese. Sci Rep (2016) 0.75
Apoptosis-Related Gene Expression Profiling in Hematopoietic Cell Fractions of MDS Patients. PLoS One (2016) 0.75
IL-4 directs the development of Th2-like helper effectors. J Immunol (1990) 7.20
Informal advice- and information-seeking between physicians. J Med Educ (1981) 3.23
Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunol Rev (1991) 3.21
OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity (2001) 3.08
Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals. J Immunol (1996) 2.76
Quantitative analysis of reproducible changes in high-voltage electrophotography. J Altern Complement Med (2001) 2.29
The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg (1999) 2.26
CD4+ T cell subsets. Lymphokine secretion of memory cells and of effector cells that develop from precursors in vitro. J Immunol (1990) 2.08
The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. J Immunol (2000) 2.04
Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg (1998) 1.95
From naive to memory T cells. Immunol Rev (1996) 1.76
Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40. J Exp Med (2001) 1.74
Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. J Immunol (1995) 1.74
Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting. Ann Thorac Surg (2000) 1.65
Self-hypnosis reduces anxiety following coronary artery bypass surgery. A prospective, randomized trial. J Cardiovasc Surg (Torino) (1997) 1.64
Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg (1995) 1.63
A direct role for IFN-gamma in regulation of Th1 cell development. J Immunol (1996) 1.56
Health family trees: a tool for finding and helping young family members of coronary and cancer prone pedigrees in Texas and Utah. Am J Public Health (1988) 1.53
Evidence-based morning report: a popular new format in a large teaching hospital. Am J Med (1997) 1.49
OX-40: life beyond the effector T cell stage. Semin Immunol (1998) 1.43
Recommendations for adopting standard conditions and analytical procedures in the measurement of serum fructosamine concentration. Ann Clin Biochem (1990) 1.43
T-cell memory: new perspectives. Immunol Today (1993) 1.43
Peptide dose, affinity, and time of differentiation can contribute to the Th1/Th2 cytokine balance. J Immunol (1999) 1.40
Signaling through OX40 (CD134) breaks peripheral T-cell tolerance. Nat Med (2001) 1.40
Molecular cloning of a functional bovine interleukin 2 cDNA. Proc Natl Acad Sci U S A (1986) 1.29
Inappropriate hospitalization of nursing facility residents: a symptom of a sick system of care for frail older people. J Am Geriatr Soc (2000) 1.29
Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis. Nat Med (1996) 1.25
Breast cancer screening: racial/ethnic differences in behaviors and beliefs. J Cancer Educ (1995) 1.23
CD28, Ox-40, LFA-1, and CD4 modulation of Th1/Th2 differentiation is directly dependent on the dose of antigen. J Immunol (2000) 1.23
Engagement of OX40 enhances antigen-specific CD4(+) T cell mobilization/memory development and humoral immunity: comparison of alphaOX-40 with alphaCTLA-4. J Immunol (2001) 1.23
Augmentation versus inhibition: effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor. J Immunol (2001) 1.19
Training generalist physicians: structural elements of the curriculum. J Gen Intern Med (1994) 1.17
Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation (1995) 1.16
The minimal number of antigen-major histocompatibility complex class II complexes required for activation of naive and primed T cells. Eur J Immunol (1997) 1.14
Optimal timing of revascularization: transmural versus nontransmural acute myocardial infarction. Ann Thorac Surg (2001) 1.14
De novo solid malignancies after cardiac transplantation. Ann Thorac Surg (1995) 1.13
Gemfibrozil-induced impotence. Lancet (1990) 1.09
Functional cooperation between T helper cell determinants. Proc Natl Acad Sci U S A (2000) 1.09
Outcomes in seriously ill neonates with coarctation of the aorta. A multiinstitutional study. J Thorac Cardiovasc Surg (1994) 1.09
Vitellogenin levels in male and female rainbow trout (Salmo gairdneri Richardson) at various stages of the reproductive cycle. Comp Biochem Physiol B (1986) 1.08
Augmentation of naive, Th1 and Th2 effector CD4 responses by IL-6, IL-1 and TNF. Eur J Immunol (1998) 1.08
Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals. Int Immunol (1996) 1.06
Phenotype of autosomal dominant cone-rod dystrophy due to the R838C mutation of the GUCY2D gene encoding retinal guanylate cyclase-1. Eye (Lond) (2006) 1.05
Presence of the T-cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers. Am J Surg (1997) 1.03
The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant (1997) 1.03
Induction of anti-mammary cancer immunity by engaging the OX-40 receptor in vivo. Breast Cancer Res Treat (2001) 1.02
Epitope affinity for MHC class I determines helper requirement for CTL priming. Nat Immunol (2000) 1.02
Inhibition of T-lymphocyte mitogenic responses and effects on cell functions by bovine herpesvirus 1. J Virol (1989) 0.99
Lymphotoxin alphabeta is expressed on recently activated naive and Th1-like CD4 cells but is down-regulated by IL-4 during Th2 differentiation. J Immunol (1999) 0.99
The evaluation of an integrated cardiovascular health education and government course in a secondary school. Health Educ (1990) 0.98
CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response. J Immunol (1997) 0.97
Pitfalls in interpreting prostate specific antigen velocity. J Urol (1996) 0.97
Breast cancer screening behaviors and intentions among asymptomatic women 50 years of age and older. Am J Prev Med (1996) 0.97
Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet (1999) 0.96
Duration of left ventricular assist device support affects transplant survival. J Heart Lung Transplant (1996) 0.95
Integrating cardiovascular health education with an English curriculum in a secondary school. J Sch Health (1984) 0.95
Modulation of naive CD4 T cell activation with altered peptide ligands: the nature of the peptide and presentation in the context of costimulation are critical for a sustained response. J Immunol (1998) 0.95
Early detection of skin cancer: racial/ethnic differences in behaviors and attitudes. J Cancer Educ (1994) 0.94
Generation, persistence, and modulation of Th0 effector cells: role of autocrine IL-4 and IFN-gamma. J Immunol (1998) 0.93
Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices. Ann Thorac Surg (1996) 0.93
Where, when, and how to detect biased expression of disease-relevant V beta genes in rats with experimental autoimmune encephalomyelitis. J Immunol (1993) 0.92
Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression. Transplantation (1997) 0.91
Co-stimulation of antigen-specific CD4 T cells by 4-1BB ligand. Eur J Immunol (2000) 0.91
Hypoplastic left heart syndrome: valuing the survival. J Thorac Cardiovasc Surg (2000) 0.90
Long-term outcomes after cardiac transplantation: an experience based on different eras of immunosuppressive therapy. Ann Thorac Surg (2001) 0.90
Human acquired naevi are clonal. Melanoma Res (1998) 0.90
Chaperones for genital examination. Chaperones should always be present. BMJ (1999) 0.90
Overexpression of mutant ras in human melanoma increases invasiveness, proliferation and anchorage-independent growth in vitro and induces tumour formation and cachexia in vivo. Melanoma Res (1999) 0.89
Expression of the T-cell activation antigen, OX-40, identifies alloreactive T cells in acute graft-versus-host disease. Blood (1997) 0.89
Ethical issues in research and publication. J Sch Health (1989) 0.88
Extended indications for lung volume reduction surgery in advanced emphysema. Ann Thorac Surg (1996) 0.88
The metabolism of cyclic nucleotides in the guinea-pig pancreas. Cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase. Biochem J (1980) 0.88
Cardiopulmonary disease in newborns: a study in continuing medical education. J Med Educ (1979) 0.87
Generation of kinins in synovial fluid from patients with arthropathy. Immunopharmacology (1997) 0.87
A randomized double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery. J Thorac Cardiovasc Surg (1999) 0.87
Quality of life with an implanted left ventricular assist device. Ann Thorac Surg (1997) 0.87
Skin cancer prevention and early detection intentions and behavior. Am J Prev Med (1995) 0.86
OX-40 antibody enhances for autoantigen specific V beta 8.2+ T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis. J Neurosci Res (1996) 0.86
OX40 ligation enhances cell cycle turnover of Ag-activated CD4 T cells in vivo. Cell Immunol (2001) 0.86
Arthroscopic washout of the knee--a 5-year survival analysis. Knee (2004) 0.85
Studies on type II collagen induced arthritis in mice. Agents Actions (1986) 0.85
The OX-40 receptor provides a potent co-stimulatory signal capable of inducing encephalitogenicity in myelin-specific CD4+ T cells. Int Immunol (1998) 0.85
Microchimerism does not induce tolerance and sustains immunity after in utero transplantation. Transplantation (2001) 0.85
Outpatient left ventricular assist device support: a destination rather than a bridge. Ann Thorac Surg (1996) 0.85
An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients. Lancet (1998) 0.85
Examining the immune response in sentinel lymph nodes of mice and men. Eur J Nucl Med (1999) 0.84
Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation. Am J Respir Crit Care Med (1998) 0.84
The isolation and properties of pig submandibular kallikrein. Biochem J (1979) 0.84
The state of school heart health education: a review of the literature. Health Educ Q (1980) 0.84
Perceived ability versus actual ability: a problem for continuing medical education. Annu Conf Res Med Educ (1977) 0.83
Accessory molecule regulation of naive CD4 T cell activation. Immunol Res (1996) 0.83
Influence of donor and recipient HLA locus mismatching on development of obliterative bronchiolitis after lung transplantation. Am J Respir Crit Care Med (2001) 0.83
Outcome of anesthesia and surgery in hypothyroid patients. Arch Intern Med (1983) 0.82
Steroid release in vitro by two luteal cell types in the corpus luteum of the pregnant sow. J Endocrinol (1977) 0.82
Multivariate analysis of factors affecting waiting time to heart transplantation. Ann Thorac Surg (1996) 0.82
Identification and functional importance of plasma kallikrein in the synovial fluids of patients with rheumatoid, psoriatic, and osteoarthritis. Ann Rheum Dis (1995) 0.81